drugset / Trial / NCT03394105

Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer

NCT03394105 ↗

Phase 2 Completed 4 enrolled Asan Medical Center
NaSingle-groupOpen-labelTreatment

Summary

In this trial, the effect of intrapleural docetaxel administration using medical pleuroscopywill be evaluated in Lung Cancer patient with malignant effusion.

Timeline

Start
2016-07-26
Primary completion
2018-06-22
Completion
2018-06-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule — Other